|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/22 | |
| A61K 31/573 | |||
| A61P 29/00 | |||
| A61P 11/06 | |||
| A61P 11/00 | |||
| A61P 37/00 |
| (11) | Patento numeris | 2533799 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11740491.3 |
| Europos patento paraiškos padavimo data | 2011-02-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-12-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/023917 |
| Data | 2011-02-07 |
| (87) | Numeris | WO 2011/097571 |
| Data | 2011-08-11 |
| (30) | Numeris | Data | Šalis |
| 201113021950 | 2011-02-07 | US | |
| 302325 P | 2010-02-08 | US |
| (72) |
DU, Tao, Tom, US
|
| (73) |
Shenzhen Evergreen Therapeutics Co., Ltd.,
62 Guimiao Road, Shuntian Tower, Suite 14A Shenzhen, Guangdong Province,
CN
|
| (54) | METHODS FOR THE USE OF PROGESTOGEN AS A GLUCOCORTICOID SENSITIZER |
| METHODS FOR THE USE OF PROGESTOGEN AS A GLUCOCORTICOID SENSITIZER |